One-Year Effectiveness and Safety of Vedolizumab Therapy for Inflammatory Bowel Disease: A Prospective Multicentre Cohort Study

Alimentary Pharmacology and Therapeutics- United Kingdom

doi 10.1111/apt.14167

Full Text

Abstract

Available in

Categories

Gastroenterology

Date

June 8, 2017

Authors

L. Peyrin-Biroulet

C. Trang-Poisson

A.-L. Pelletier

Publisher

Wiley

Related search

Early Vedolizumab Trough Levels Predict Mucosal Healing in Inflammatory Bowel Disease: A Multicentre Prospective Observational Study

Alimentary Pharmacology and Therapeutics

Gastroenterology

English

Effects of Vedolizumab Therapy on Extraintestinal Manifestations in Inflammatory Bowel Disease

Digestive Diseases and Sciences

Gastroenterology

English

Letter: Vedolizumab for Autoimmune Liver Disease Associated Inflammatory Bowel Disease-Authors’ Reply

Alimentary Pharmacology and Therapeutics

Gastroenterology

English

Diagnostic Accuracy of Fecal Calprotectin for Pediatric Inflammatory Bowel Disease in Primary Care: A Prospective Cohort Study

Annals of Family Medicine

Family Practice

English

Anthroposophic Medical Therapy in Chronic Disease: A Four-Year Prospective Cohort Study

BMC Complementary and Alternative Medicine

Alternative Medicine

English

Rhythmical Massage Therapy in Chronic Disease: A 4-Year Prospective Cohort Study

Journal of Alternative and Complementary Medicine

Alternative Medicine

English

Vedolizumab for Inflammatory Bowel Disease: Changing the Game, or More of the Same?

United European Gastroenterology Journal

Gastroenterology

English

Review Article: Predictors of Response to Vedolizumab and Ustekinumab in Inflammatory Bowel Disease

Alimentary Pharmacology and Therapeutics

Gastroenterology

English

Anthroposophic Therapy for Children With Chronic Disease: A Two-Year Prospective Cohort Study in Routine Outpatient Settings

English